- Home
- ELVN vs GTX Comparison
ELVN vs GTX Comparison
Compare ELVN & GTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELVN | GTX |
|---|---|---|
| Founded | 2016 | 2018 |
| Country | United States | United States |
| Employees | N/A | 6700 |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 4.1B |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ELVN | GTX |
|---|---|---|
| Price | $41.41 | $21.66 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 6 |
| Target Price | ★ $73.92 | $35.33 |
| AVG Volume (30 Days) | 1.2M | ★ 2.6M |
| Earning Date | 11-11-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 1.46% |
| EPS Growth | 3.17 | ★ 20.63 |
| EPS | N/A | ★ 0.49 |
| Revenue | N/A | ★ $3,584,000,000.00 |
| Revenue This Year | N/A | $6.63 |
| Revenue Next Year | N/A | $3.74 |
| P/E Ratio | ★ N/A | $44.90 |
| Revenue Growth | N/A | ★ 3.14 |
| 52 Week Low | $14.79 | $15.54 |
| 52 Week High | $62.32 | $36.25 |
Technical Indicators
Market Signals| Indicator | ELVN | GTX |
|---|---|---|
| Relative Strength Index (RSI) | 39.47 | 23.89 |
| Support Level | $37.77 | $17.41 |
| Resistance Level | $43.05 | $27.96 |
| Average True Range (ATR) | 1.84 | 0.86 |
| MACD | 0.57 | -0.35 |
| Stochastic Oscillator | 50.69 | 13.80 |
Price Performance
Historical ComparisonAbout ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About GTX Garrett Motion Inc.
Garrett Motion Inc designs, manufactures and sells engineered turbocharger and electric-boosting technologies for light and commercial vehicle original equipment manufacturers (OEMs). The company is a technology leader with expertise in delivering products across gasoline, diesel, natural gas and electrified powertrains. The company also sells its technologies in the aftermarket through its distribution network. The company derives maximum of its revenue from Gas and geographically from Europe.